Hanne M. Lindegaard

Hanne M. Lindegaard is a Clinical Lector at the Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark (SDU), and is affiliated with the Research Unit of Rheumatology at Odense University Hospital (OUH). She has held this academic position since January 2008 and concurrently serves as a senior consultant rheumatologist, reflecting her dual clinical and research expertise.

Her educational background includes a PhD in 2002 on early rheumatoid arthritis, focusing on clinical aspects, skeletal imaging, and joint metabolism, and a medical degree (Medicinsk embedseksamen) from Aarhus University in 1991. She became a certified specialist in rheumatology in 2006.

Hanne M. Lindegaard's research primarily centers on inflammatory and rheumatoid arthritis, with a strong emphasis on disease remission, treatment strategies using biological agents, and the application of magnetic resonance imaging (MRI) for monitoring disease progression. Her work explores the efficacy of treat-to-target protocols and the safety of biologic therapies, including in special populations such as pregnant patients.

Her recent publications reveal a sustained focus on clinical outcomes in rheumatoid arthritis, the impact of immune-modulating therapies in comorbid conditions like melanoma, and contributions to medical education. The integration of imaging, biomarkers, and clinical metrics underscores her translational research approach.

Scientific Awards:

• No awards explicitly mentioned in the provided text.

Dr. Lindegaard has been actively involved in academic supervision, serving as an examiner (censor) for Master’s theses, and has participated in national registries such as DANBIO. She has contributed to conference organization and delivered presentations on cardiovascular aspects in rheumatoid arthritis and rheumatology education. While no specific grants are listed, her extensive research output and leadership in clinical trials suggest active grant-supported work.

She is associated with the Research Unit of Rheumatology at Odense, contributing to a multidisciplinary team focused on improving outcomes in autoimmune joint diseases through evidence-based practice and innovation in treatment monitoring.